Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

BLU

BELLUS Health (BLU)

BELLUS Health Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BLU
일자시간출처헤드라인심볼기업
2024/01/3100:56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLUBELLUS Health Inc
2023/08/1506:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLUBELLUS Health Inc
2023/07/1021:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:BLUBELLUS Health Inc
2023/06/2906:22Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:BLUBELLUS Health Inc
2023/06/2906:21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLUBELLUS Health Inc
2023/06/2906:21Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:BLUBELLUS Health Inc
2023/06/2906:20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLUBELLUS Health Inc
2023/06/2905:57Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLUBELLUS Health Inc
2023/06/2905:11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:BLUBELLUS Health Inc
2023/06/2905:10Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:BLUBELLUS Health Inc
2023/06/2903:42Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLUBELLUS Health Inc
2023/06/2900:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/06/2900:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLUBELLUS Health Inc
2023/06/2823:59PR Newswire (Canada)Annonce boursière - Réservée aux médias et aux investisseurs - GSK mène à terme l'acquisition de BELLUS SantéNASDAQ:BLUBELLUS Health Inc
2023/06/2823:57PR Newswire (Canada)Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS HealthNASDAQ:BLUBELLUS Health Inc
2023/06/1702:50Business WireBELLUS Health Inc. Announces Voting Results from Special Meeting of ShareholdersNASDAQ:BLUBELLUS Health Inc
2023/06/1702:50Business WireBELLUS Santé inc. annonce les résultats du vote tenu à l’assemblée extraordinaire des actionnairesNASDAQ:BLUBELLUS Health Inc
2023/06/0705:07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/05/2006:28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/05/1706:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/05/1706:01Business WireBELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK AcquisitionNASDAQ:BLUBELLUS Health Inc
2023/05/1706:01Business WireBELLUS Santé inc. convoque une assemblée extraordinaire des actionnaires concernant l’acquisition de la société par GSKNASDAQ:BLUBELLUS Health Inc
2023/05/1305:33Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/05/1305:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/05/1305:01Business WireBELLUS Santé annonce ses résultats financiers et faits saillants pour le premier trimestre de 2023NASDAQ:BLUBELLUS Health Inc
2023/05/1305:01Business WireBELLUS Health Reports First Quarter 2023 Financial Results and Business HighlightsNASDAQ:BLUBELLUS Health Inc
2023/04/2900:14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/04/2719:07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/04/2719:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLUBELLUS Health Inc
2023/04/2707:00Business WireBELLUS Health Announces Meeting UpdatesNASDAQ:BLUBELLUS Health Inc
 검색 관련기사 보기:NASDAQ:BLU